Impact of reactive oxygen species on the expression of adhesion molecules in vivo

Advances in Experimental Medicine and Biology

Volumn 645, Issue , 2009, Pages 95-100

  Thews, Oliver ^a   Lambert, Christine ^b   Kelleher, Debra K ^a   Biesalski, Hans K ^b   Vaupel, Peter ^a   Frank, Juergen ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; ALPHA5 INTEGRIN; BETA3 INTEGRIN; BETA5 INTEGRIN; CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE; REACTIVE OXYGEN METABOLITE; UVOMORULIN; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL PROTECTION; CONFERENCE PAPER; CONTROLLED STUDY; IN VIVO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; ARTICLE; METABOLISM; PROTEIN MULTIMERIZATION; SARCOMA; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; CELL ADHESION MOLECULES; INTEGRIN ALPHAVBETA3; MALE; PROTEIN MULTIMERIZATION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SARCOMA;

EID: 61849136171     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-85998-9_15     Document Type: Conference Paper

References (14)

1. J. D. Hood and D. A. Cheresh. Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2, 91-100(2002). (Pubitemid 37328796)
2. I. R. Beavon. The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur. J. Cancer 36, 1607-1620(2000). (Pubitemid 30616365)
3. S. Hirohashi and Y. Kanai. Cell adhesion system and human cancer morphogenesis. Cancer Sci. 94, 575-581(2003). (Pubitemid 36975010)
4. R. A. Cairns, R. Khokha, and R. P. Hill. Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr. Mol. Med. 3, 659-671(2003). (Pubitemid 37236408)
5. W. S. Wu. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 25, 695-705(2006).
6. P. Workman, P. Twentyman, F. Balkwill, A. Balmain, D. J. Chaplin, J. A. Double, et al. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (2nd edit.). Br. J. Cancer 77, 1-10(1998). (Pubitemid 28029765)
7. J. Frank, D. K. Kelleher, A. Pompella, O. Thews, H. K. Biesalski, and P. Vaupel. Enhancement of oxidative cell injury and antitumor effects of localized 44°C hyperthermia upon combination with respiratory hyperoxia and xanthine oxidase. Cancer Res. 58, 2693-2698(1998). (Pubitemid 28311891)
8. O. Thews, C. Lambert, D. K. Kelleher, H. K. Biesalski, P. Vaupel, and J. Frank. Possible protective effects of α-tocopherol on enhanced induction of reactive oxygen species by 2-methoxyestradiol in tumors. Adv. Exp. Med. Biol. 566, 349-355(2005). (Pubitemid 43779522)
9. K. Mori, M. Shibanuma, and K. Nose. Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res. 64, 7464-7472(2004). (Pubitemid 39372089)
10. R. K. Rao, S. Basuroy, V. U. Rao, K. J. Karnaky Jr, and A. Gupta. Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-β-catenin complexes from the cytoskeleton by oxidative stress. Biochem. J. 368, 471-481(2002). (Pubitemid 35454525)
11. M. Bockhorn, S. Roberge, C. Sousa, R. K. Jain, and L. L. Munn. Differential gene expression in metastasizing cells shed from kidney tumors. Cancer Res. 64, 2469-2473(2004). (Pubitemid 38523901)
12. A. Enns, T. Korb, K. Schlüter, P. Gassmann, H. U. Spiegel, N. Senninger, F. Mitjans, and J. Haier. αvβ5-integrins mediate early steps of metastasis formation. Eur. J. Cancer 41, 1065-1072(2005). (Pubitemid 40602860)
13. J. F. Harms, D. R. Welch, R. S. Samant, L. A. Shevde, M. E. Miele, G. R. Babu et al. A small molecule antagonist of the αvβ3 integrin suppresses MDA-MB-435 skeletal metastasis. Clin. Exp. Metastasis 21, 119-128(2004). (Pubitemid 38988085)
14. D. G. McNeel, J. Eickhoff, F. T. Lee, D. M. King, D. Alberti, J. P. Thomas et al. Phase I trial of a monoclonal antibody specific for αvβ3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion. Clin. Cancer Res. 11, 7851-7860(2005). (Pubitemid 41611630)